Throughout the world asthma is the most common chronic lower respiratory disease in childhood. There are several guidelines supporting medical decisions on paediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these, these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI, and WAO, has proposed an international consensus on (ICON) paediatric asthma. The aim was to highlight the key information common to the existing guidelines as well as review and comment gap thus providing a concise reference. Generally the principles of paediatric asthma management are being accepted. Overall, the treatment goal is a disease control. In order to achieve this, patients and their parents should be educated to optimally manage a disease, in collaboration with healthcare professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent of chronic treatment. There is a trend toward considering phenotype-specific treatment choices however this goal has not yet been achieved.